Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

Kyowa Kirin’s Crysvita secures CHMP support in rare X-linked hypophosphataemia

July 28, 2020 Manufacturing and Production, Sales and Marketing CHMP, EMA

The European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) has given its backing to Kyowa Kirin’s …
News

Celltrion’s infliximab biosimilar Remsima secures European approval in five indications

July 27, 2020 Manufacturing and Production, Sales and Marketing celltrion, infliximab, pharma, remsima

The subcutaneous (SC) formulation of Remsima, Celltrion’s biosimilar version of infliximab, has secured approval from the European Commission covering five …
News

AstraZeneca partners with Daichii Sankyo in potential $6bn cancer drug deal

July 27, 2020 Research and Development, Sales and Marketing AstraZeneca, Daiichi Sankyo, partnership, pharma

AstraZeneca and Daiichi Sankyo have joined forces to drive the development and commercialisation of the latter’s DS-1062, a trophoblast cell-surface …
News

US Government invests a further $472 million in Moderna’s BARDA-backed COVID-19 vaccine

July 27, 2020 Research and Development, Sales and Marketing COVID-19, Moderna, US government, Vaccine

Moderna has revealed a second investment of $472 million from the US Government’s Biomedical Advanced Research and Development Authority (BARDA) to support …
News

India’s National Task Force rejects Biocon’s itolizumab for COVID-19

July 27, 2020 Sales and Marketing Biocon, COVID-19, India, Itolizumab

Biocon was hit with bad news over the weekend as the National Task Force for COVID-19 in its home country …
News

Kite secures FDA approval for second CAR T therapy Tecartus in relapsed or refractory mantle cell lymphoma

July 27, 2020 Sales and Marketing CAR T, CAR-T, FDA, Gilead, kite pharma

Kite Pharma has chalked up another regulatory success for its parent company Gilead with the news that the FDA has …
News

Two CHMP recommendations for AstraZeneca: Imfinzi in first-line lung cancer, Calquence in chronic lymphocytic leukaemia

July 27, 2020 Sales and Marketing AstraZeneca, CHMP, Calquence, EMA, Imfinzi

AstraZeneca has secured two new recommendations for approval of its products from the European Medicines Agency’s Committee for Medicinal Products …
News

Top Ten most popular articles on Pharmafile.com this week

July 24, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus, top 10, top 10 stories

As the coronavirus pandemic shows no signs of slowing down, an Israeli doctor has appeared to have contracted COVID-19 for …
News

David Meeker appointed Chief Executive Officer of Rhythm Pharmaceuticals

July 23, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Rhythm Pharmaceuticals have appointed David Meeker, M.D., as its Chief Executive Officer and President of the company. Meeker succeeds interim …
Appointment

Executives at Novavax expected to get big payouts, even if their vaccine fails clinical trials

July 23, 2020 Medical Communications, Sales and Marketing COVID Vaccine, Vaccine, coronavirus

Novavax, one of the leading US firms which is developing a coronavirus vaccine, is set to award executives stock options …
News

Is Pharma doing enough on sustainability?

July 20, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing antimicrobial resistance, manufacturing, pharma, sustainability

Adoption of sustainable practices in pharmaceutical operations is ticking along, but given the environmental and health risks if this is …
Feature

Mylan launches generic version of Gilead’s remdesivir for COVID-19 patients in India

July 20, 2020 Sales and Marketing COVID-19, Gilead, India, Mylan, generic, remdesivir

Mylan has launched its own generic version of Gilead’s remdesivir on the Indian market for the treatment of patients with …
News

Synairgen drug doubles likelihood of recovery in hospitalised COVID-19 patients, early data show

July 20, 2020 Research and Development, Sales and Marketing COVID-19, Synairgen

Respiratory drug firm Synairgen has, like many, been hard at work on a treatment for patients with COVID-19; the company …
News

Israeli doctor tests positive for coronavirus 3 months after recovering

July 20, 2020 Sales and Marketing COVID-19, coronavirus

An Israeli doctor has appeared to have contracted COVID-19 for a second time after they tested positive for the virus …
News

England’s test and trace system breaks GDPR data law, according to privacy group

July 20, 2020 Sales and Marketing Contact tracing, GDPR, coronavirus, covid19

England’s test and trace programme broke General Data Protection Regulation (GDPR) data law according to the Open Rights Group (ORG). …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026